Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 15
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    The Red Devil squid: Oxygen deprived, cold, and under pressure

    At night the Red Devil (Humboldt) squid rises to the ocean’s surface to feed, but come morning, it begins its...

    Should I stay or should I go? Connecting bird behavior during migration to fat stores and antioxidant capacity

    Thank you to our backers for $5600! We actually need up to $24000 - please keep donating! In the fall, most...

    Backer Badge Funded